NATCO Pharma Limited (BOM:524816)
888.75
+5.50 (0.62%)
At close: Jun 19, 2026
NATCO Pharma Employees
NATCO Pharma had 4,199 employees as of March 31, 2025. The number of employees increased by 183 or 4.56% compared to the previous year.
Employees
4,199
Change (1Y)
183
Growth (1Y)
4.56%
Revenue / Employee
9.71M INR
Profits / Employee
3.38M INR
Market Cap
158.39B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,199 | 183 | 4.56% |
| Mar 31, 2024 | 4,016 | 70 | 1.77% |
| Mar 31, 2023 | 3,946 | -79 | -1.96% |
| Mar 31, 2022 | 4,025 | -1,021 | -20.23% |
| Mar 31, 2021 | 5,046 | 20 | 0.40% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 5,602 |
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 4,500 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| GlaxoSmithKline Pharmaceuticals | 3,103 |
| Procter & Gamble Health | 1,326 |
| Viyash Scientific | 1,244 |
NATCO Pharma News
- 4 days ago - Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01% - Business Upturn
- 10 days ago - Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36% - Business Upturn
- 17 days ago - Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79% - Business Upturn
- 18 days ago - Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63% - Business Upturn
- 19 days ago - Lupin And Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 19 days ago - Lupin, Natco Receive FDA Approval For Eribulin Mesylate Injection - Nasdaq
- 19 days ago - Natco Pharma and Lupin secure U.S. FDA approval for Eribulin Mesylate Injection - Business Upturn
- 19 days ago - Pharma sector stocks today, June 3: Natco Pharma falls 2.57%, Zydus Lifesciences falls 1.26%, Alembic Pharma down 1.06% - Business Upturn